SAH (SUBARACHNOID HEMORRHAGE)
Clinical trials for SAH (SUBARACHNOID HEMORRHAGE) explained in plain language.
Never miss a new study
Get alerted when new SAH (SUBARACHNOID HEMORRHAGE) trials appear
Sign up with your email to follow new studies for SAH (SUBARACHNOID HEMORRHAGE), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a cystic fibrosis drug help brain bleed survivors walk again?
Disease control Recruiting nowThis study tests whether giving dornase alfa (a drug already used for cystic fibrosis) daily for up to 14 days after a brain bleed from a ruptured aneurysm can help people recover better. The goal is to see if more patients can live independently at 6 months. The trial will enrol…
Matched conditions: SAH (SUBARACHNOID HEMORRHAGE)
Phase: PHASE2 • Sponsor: Fondation Ophtalmologique Adolphe de Rothschild • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Nerve block may ease headaches after brain bleeding, reduce opioid use
Symptom relief Recruiting nowThis study tests a nerve block (sphenopalatine ganglion block) given through the nose to treat severe headaches after a type of brain bleed called subarachnoid hemorrhage. About 40 adults with a secured aneurysm will receive either the block plus standard pain meds or standard me…
Matched conditions: SAH (SUBARACHNOID HEMORRHAGE)
Phase: PHASE2, PHASE3 • Sponsor: University of California, Davis • Aim: Symptom relief
Last updated Jun 27, 2026 08:00 UTC